Trial Profile
A Phase II Trial of Stanford VI ± Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease With 3+ Risk Factors: the G6 Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2014
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine (Primary) ; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Vinblastine; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Acronyms G6 Study
- 30 Aug 2014 New trial record